Recent Patents on Endocrine, Metabolic Immune Drag Discovery is an important addition to the 'Recent Patent' journal series published by Bentham Science Publishers. The journal publishes review and research articles and thematic issues on recent patents reviewed in the field. The scope of the journal covers therapeutic targets/ agents associated with endocrine, metabolic and immune drag discovery; novel drags/ hormone for the treatment of diabetes, cardiovascular, obesity, endocrine glands and hormones , and related areas. In this issue, Cheung and Tang discusses the role of adrenomedullin in many biological systems particularly cardiovascular, endocrine, immune, musculoskeletal infection, reproductive, neuroendocrine and renal functions. The recent patents cited in this article claims the use of peptide from human pheochromocytoma tissue in diabetes and cardiovascular diseases and blocking angiogenesis in cancers. Adrenomedullin also acts as an endocrine biomarker in diabetes and cardocascular diseases and also acts as growth factor in proliferation of osteoblasts. The diagnostic applications of adrenomedullin was also discussed.
展开▼
